Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.

Nicoletti F, Mazzon E, Fagone P, Mangano K, Mammana S, Cavalli E, Basile MS, Bramanti P, Scalabrino G, Lange A, Curtin F.

J Neuroimmunol. 2019 May 8;332:224-232. doi: 10.1016/j.jneuroim.2019.05.006. [Epub ahead of print]

PMID:
31100693
2.

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.

Paskaš S, Krajnović T, Basile MS, Dunđerović D, Cavalli E, Mangano K, Mammana S, Al-Abed Y, Nicoletti F, Mijatović S, Maksimović-Ivanić D.

Mol Carcinog. 2019 Apr 17. doi: 10.1002/mc.23020. [Epub ahead of print]

PMID:
30997718
3.

KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms.

Basile MS, Fagone P, Mangano K, Mammana S, Magro G, Salvatorelli L, Li Destri G, La Greca G, Nicoletti F, Puleo S, Pesce A.

Cancers (Basel). 2019 Feb 19;11(2). pii: E245. doi: 10.3390/cancers11020245.

4.

Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis.

Fagone P, Mazzon E, Chikovani T, Saraceno A, Mammana S, Colletti G, Mangano K, Bramanti P, Nicoletti F.

J Neuroimmunol. 2018 Aug 15;321:41-48. doi: 10.1016/j.jneuroim.2018.05.013. Epub 2018 May 28.

5.

Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.

Fagone P, Mazzon E, Cavalli E, Bramanti A, Petralia MC, Mangano K, Al-Abed Y, Bramati P, Nicoletti F.

J Neuroimmunol. 2018 Sep 15;322:46-56. doi: 10.1016/j.jneuroim.2018.06.009. Epub 2018 Jun 15.

6.

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.

Mangano K, Mazzon E, Basile MS, Di Marco R, Bramanti P, Mammana S, Petralia MC, Fagone P, Nicoletti F.

Oncotarget. 2018 Apr 3;9(25):17951-17970. doi: 10.18632/oncotarget.24885. eCollection 2018 Apr 3. Review.

7.

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis.

Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F, Mangano K.

Oncotarget. 2018 Jan 3;9(9):8263-8277. doi: 10.18632/oncotarget.23862. eCollection 2018 Feb 2.

8.

Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production.

Inturri R, Mangano K, Santagati M, Intrieri M, Di Marco R, Blandino G.

Curr Pharm Biotechnol. 2017;18(11):883-889. doi: 10.2174/1389201019666171226151551.

PMID:
29278212
9.

Effects of a new combination of  plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections.

Genovese C, Davinelli S, Mangano K, Tempera G, Nicolosi D, Corsello S, Vergalito F, Tartaglia E, Scapagnini G, Di Marco R.

J Chemother. 2018 Apr;30(2):107-114. doi: 10.1080/1120009X.2017.1393587. Epub 2017 Oct 27.

PMID:
29078739
10.

Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis.

Mangano K, Cavalli E, Mammana S, Basile MS, Caltabiano R, Pesce A, Puleo S, Atanasov AG, Magro G, Nicoletti F, Fagone P.

J Cell Physiol. 2018 May;233(5):4156-4165. doi: 10.1002/jcp.26223. Epub 2017 Dec 29.

PMID:
29034470
11.

Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone.

Mangano K, Vergalito F, Mammana S, Mariano A, De Pasquale R, Meloscia A, Bartollino S, Guerra G, Nicoletti F, Di Marco R.

Exp Ther Med. 2017 Sep;14(3):2439-2444. doi: 10.3892/etm.2017.4810. Epub 2017 Jul 19.

12.

Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents.

Nikolic I, Stojanovic I, Vujicic M, Fagone P, Mangano K, Stosic-Grujicic S, Nicoletti F, Saksida T.

Immunobiology. 2017 Feb;222(2):272-279. doi: 10.1016/j.imbio.2016.09.013. Epub 2016 Sep 24.

PMID:
27693017
13.

Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study.

Signorelli SS, Anzaldi M, Libra M, Navolanic PM, Malaponte G, Mangano K, Quattrocchi C, Di Marco R, Fiore V, Neri S.

Angiology. 2016 Oct;67(9):870-4. doi: 10.1177/0003319716633339. Epub 2016 Feb 17.

PMID:
26888895
14.

Expression of DNA methylation genes in secondary progressive multiple sclerosis.

Fagone P, Mangano K, Di Marco R, Touil-Boukoffa C, Chikovan T, Signorelli S, Lombardo GA, Patti F, Mammana S, Nicoletti F.

J Neuroimmunol. 2016 Jan 15;290:66-9. doi: 10.1016/j.jneuroim.2015.11.018. Epub 2015 Nov 24.

PMID:
26711572
15.

Emerging therapeutic targets for the treatment of hepatic fibrosis.

Fagone P, Mangano K, Pesce A, Portale TR, Puleo S, Nicoletti F.

Drug Discov Today. 2016 Feb;21(2):369-75. doi: 10.1016/j.drudis.2015.10.015. Epub 2015 Oct 30. Review.

PMID:
26523773
16.

Identification of novel targets for the diagnosis and treatment of liver fibrosis.

Fagone P, Mangano K, Mammana S, Pesce A, Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E, Lombardo GA, Coco M, Puleo S, Nicoletti F.

Int J Mol Med. 2015 Sep;36(3):747-52. doi: 10.3892/ijmm.2015.2264. Epub 2015 Jun 29.

PMID:
26135677
17.

Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.

Conway TF, Hammer L, Furtado S, Mathiowitz E, Nicoletti F, Mangano K, Egilmez NK, Auci DL.

J Crohns Colitis. 2015 Aug;9(8):647-58. doi: 10.1093/ecco-jcc/jjv089. Epub 2015 May 18.

18.

Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir.

Fagone P, Mangano K, Quattrocchi C, Cavalli E, Mammana S, Lombardo GA, Pennisi V, Zocca MB, He M, Al-Abed Y, Nicoletti F.

Basic Clin Pharmacol Toxicol. 2015 Nov;117(5):306-15. doi: 10.1111/bcpt.12414. Epub 2015 May 25.

19.

Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats.

Fagone P, Mangano K, Mammana S, Cavalli E, Di Marco R, Barcellona ML, Salvatorelli L, Magro G, Nicoletti F.

Clin Immunol. 2015 Apr;157(2):198-204. doi: 10.1016/j.clim.2015.02.002. Epub 2015 Feb 19.

PMID:
25701800
20.

Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties.

Celasco G, Moro L, Aiello C, Mangano K, Milasi A, Quattrocchi C, DI Marco R.

Biomed Rep. 2014 Jul;2(4):559-563. Epub 2014 May 8.

Supplemental Content

Loading ...
Support Center